Dr. Adsit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9025 Balboa Ave
Suite 105
San Diego, CA 92123Phone+1 858-571-6800Fax+1 858-571-6801
Education & Training
- Naval Medical Center (San Diego)Residency, Dermatology, 1985 - 1988
- Naval Medical Center (San Diego)Internship, Transitional Year, 1981 - 1982
- University of Pittsburgh School of MedicineClass of 1981
Certifications & Licensure
- CA State Medical License 1990 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- 9 citationsSecukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.Sandra Adsit, Enrique Rivas Zaldivar, Howard Sofen, Ignacio Dei-Cas, César Maldonado-García
Advances in Therapy. 2017-06-01 - Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.Sandra Adsit, Enrique Rivas Zaldivar, Howard Sofen, Ignacio Dei-Cas, César Maldonado-García
Advances in Therapy. 2017-07-01
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: